(S (S (NP (NP (DT The) (JJ opioid) (NN epidemic)) (PP (IN in) (NP (DT the) (NNP United) (NNP States)))) (VP (VBZ claims) (PP (IN over) (NP (NP (CD 40,000) (NNS lives)) (PP (IN per) (NP (NN year))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN estimated) (SBAR (IN that) (S (NP (QP (RB well) (IN over) (CD two) (CD million)) (NNPS Americans)) (VP (VBP have) (NP (DT an) (JJ opioid) (NN use) (NN disorder)))))))) (. .))
(S (NP (NP (NN Over-prescription) (CC and) (NN misuse)) (PP (IN of) (NP (NN prescription) (NNS opioids)))) (VP (VBP play) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (DT the) (NN epidemic))))) (. .))
(S (NP (NP (NNS Individuals)) (SBAR (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN prescribed) (NP (NNS opioids)))))) (, ,) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN diagnosed) (PP (IN with) (NP (JJ opioid) (NN use) (NN disorder))))))))) (, ,) (VP (VBP have) (NP (JJ diverse) (VBG underlying) (NN health) (NNS states))) (. .))
(S (NP (NP (NN Policy) (NNS interventions)) (VP (VBG targeting) (NP (NP (NN prescription) (JJ opioid) (NN use)) (, ,) (NP (JJ opioid) (NN use) (NN disorder)) (, ,) (CC and) (NP (NN overdose))))) (ADVP (RB often)) (VP (VBP fail) (S (VP (TO to) (VP (VB account) (PP (IN for) (NP (DT this) (NN variation))))))) (. .))
(S (S (VP (TO To) (VP (VB identify) (NP (NP (NN latent) (NN health) (NNS states)) (, ,) (CC or) (NP (NNS phenotypes)) (, ,)) (S (ADJP (JJ pertinent))) (PP (IN to) (NP (NP (JJ opioid) (NN use)) (CC and) (NP (JJ opioid) (NN use) (NNS disorders))))))) (, ,) (NP (PRP we)) (VP (VBP use) (NP (NP (JJ probabilistic) (NN topic) (NN modeling)) (PP (IN with) (NP (JJ medical) (NN diagnosis) (NNS histories)))) (PP (IN from) (NP (NP (DT a) (JJ statewide) (NN population)) (PP (IN of) (NP (NP (NNS individuals)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN prescribed) (NP (NNS opioids))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (PRP$ our) (NML (S (VP (VBN learned)))) (NNS phenotypes)) (VP (VBP are) (ADJP (JJ predictive) (PP (IN of) (NP (JJ future) (ADJP (NP (JJ opioid) (NN use)) (HYPH -) (VBN related)) (NNS outcomes)))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (WHADVP (WRB how)) (S (NP (DT the) (NML (S (VP (VBN learned)))) (NNS phenotypes)) (VP (MD can) (VP (VB provide) (NP (JJ important) (NN context)) (PP (IN for) (NP (NP (NN variability)) (PP (IN in) (NP (JJ opioid) (NNS prescriptions)))))))))) (. .))
(S (S (VP (VBG Understanding) (NP (NP (DT the) (NN heterogeneity)) (PP (IN in) (NP (JJ individual) (NN health) (NNS states)))))) (CC and) (S (PP (IN in) (NP (NN prescription))) (NP (JJ opioid) (NN use)) (VP (MD can) (VP (VB help) (S (VP (VB identify) (NP (NN policy) (NNS interventions)) (S (VP (TO to) (VP (VB address) (NP (DT this) (NML (JJ public) (NN health)) (NN crisis)))))))))) (. .))
